Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01415115 · ClinicalTrials.gov registry record
Using SCOUT Noninvasive AGE Measurements to Forecast Diabetes Complications
A clinical trial, sponsored by VeraLight.
- Completed
- Registry status
- 250
- Enrollment target
NCT01415115: Completed study, sponsored by VeraLight.
NCT01415115 is a clinical trial that has completed, run by VeraLight. The registered enrollment target is 250 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01415115 has completed, sponsored by VeraLight.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
Study Summary
The trial is designed as a feasibility study to determine the correlation of noninvasive measurements of AGE with the SCOUT device to diabetes complications.
Primary Outcome
This cross-sectional study will test the hypothesis that the correlation between quantitative measurements of skin AGEs by SCOUT noninvasive fluorescence technique, and aggregate diabetic complications, is statistically equivalent to the correlation between the aggregate complications and either disease duration, concurrent HbA1c or individual complications (retinopathy, nephropathy, neuropathy, hypertension and dyslipidemia).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2007-03 |
| Est. Completion | 2011-08 |
What the finished NCT01415115 record still lists
NCT01415115 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01415115 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01415115 about?
NCT01415115 is a clinical study titled "Using SCOUT Noninvasive AGE Measurements to Forecast Diabetes Complications". The trial is designed as a feasibility study to determine the correlation of noninvasive measurements of AGE with the SCOUT device to diabetes complications.
What is the current status of trial NCT01415115?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2007-03. Estimated completion is 2011-08.
Who is sponsoring clinical trial NCT01415115?
This trial is sponsored by VeraLight, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia